IBERE PHARMACEUTICALS's ticker is IBER and the CUSIP is G46843101. A total of 33 filers reported holding IBERE PHARMACEUTICALS in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,746,286 | +5.0% | 470,395 | +3.1% | 0.20% | +55.7% |
| Q3 2022 | $4,521,000 | +30.0% | 456,170 | +28.6% | 0.13% | +40.9% |
| Q2 2022 | $3,479,000 | 0.0% | 354,600 | 0.0% | 0.09% | +4.5% |
| Q1 2022 | $3,479,000 | +28.2% | 354,600 | +26.8% | 0.09% | +21.9% |
| Q4 2021 | $2,713,000 | +832.3% | 279,600 | +832.0% | 0.07% | +711.1% |
| Q3 2021 | $291,000 | +0.3% | 30,000 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $290,000 | – | 30,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |